Neuregulin-1NeuregulinsReceptor, erbB-3Receptor, Epidermal Growth FactorReceptor, erbB-2SNARE ProteinsBone Morphogenetic Protein Receptors, Type IIBone Morphogenetic Protein Receptors, Type IEpidermal Growth FactorGenes, erbBAntineoplastic AgentsQa-SNARE ProteinsXenograft Model Antitumor AssaysDrug Screening Assays, AntitumorR-SNARE ProteinsBone Morphogenetic Protein ReceptorsCell Line, TumorVesicular Transport ProteinsLeukemia P388Vesicle-Associated Membrane Protein 2Mice, NudeSynaptosomal-Associated Protein 25Sarcoma 180Syntaxin 1Qb-SNARE ProteinsMunc18 ProteinsNeoplasms, ExperimentalNeoplasm TransplantationQc-SNARE ProteinsAntibiotics, AntineoplasticExocytosisLeukemia L1210Tumor Cells, CulturedMembrane FusionNeoplasmsCell ProliferationMice, Inbred BALB CMelanoma, ExperimentalSignal TransductionSoluble N-Ethylmaleimide-Sensitive Factor Attachment ProteinsMembrane ProteinsDrug SynergismDose-Response Relationship, DrugMice, SCIDApoptosisTransplantation, HeterologousAntineoplastic Agents, PhytogenicProtein BindingMice, Inbred C57BLSyntaxin 16Botulinum ToxinsSynaptotagmin IReceptor, Parathyroid Hormone, Type 1Synaptotagmin IIAntibodies, MonoclonalSynaptotagminsInhibitory Concentration 50Cell SurvivalN-Ethylmaleimide-Sensitive ProteinsImmunotherapyImmunotoxinsReceptors, Parathyroid HormoneTetanus ToxinCancer VaccinesMolecular Sequence DataLung NeoplasmsQuinazolinesCell LineBreast NeoplasmsVesicle-Associated Membrane Protein 3LiposomesColonic NeoplasmsHypertension, PulmonaryTumor BurdenAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleRecombinant Fusion ProteinsImmunotherapy, AdoptiveAngiogenesis InhibitorsOncogene Proteins v-erbBMelanomaAmino Acid SequenceRecombinant ProteinsCell DivisionPhosphorylationStructure-Activity RelationshipSynaptic VesiclesProtein Structure, TertiaryDoxorubicinNerve Tissue ProteinsBlotting, WesternFibrosarcomaDrug Resistance, NeoplasmSarcoma, ExperimentalMice, Inbred DBACamptothecinCell MembraneReceptors, Cell SurfaceProtein TransportProtein Kinase Inhibitors